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Copyright © 2009 JCBN Summary Epidemiologic investigations indicate a close relationship between colorectal
cancer and fat intake. However, to date the effects of lipid peroxidation-derived products that
are formed from fat (especially free or esterified unsaturated fatty acids) on the initiation or
progression of colorectal cancer have not been investigated extensively. Therefore, in the
present study, we examined the effects of fatty acids, fatty acid hydroperoxides and aldehydes
on the growth of human colorectal cancer cell line HT-29. At concentrations of 1 and 10 µM,
linoleic, arachidonic and eicosapentaenoic acids, and 13-hydroperoxyoctadecadienoic and 15-
hydroperoxyeicosapentaenoic acids had no significant effects on the growth of HT-29 cells. 4-
Hydroxynonenal and 4-hydroxyhexenal had no significant effects on the growth of HT-29 cells
up to 10 µM, whereas 4-oxononenal potently inhibited HT-29 cell growth (1–10 µM, 16–85%
inhibition). Further experiments concerning DNA fragmentation, expression levels of Bax
and Bcl-2 mRNA, expression levels of pro-caspase-3 and caspase-3 proteins, and activity of
caspase-3 suggested that 4-oxononenal may increase the sensitivity of HT-29 cells to apoptosis
through a decreased expression level of Bcl-2 and then increased formation of caspase-3 from
pro-caspase-3.
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Introduction
Colon cancer is a serious health problem in most developed
countries and is the main cause of cancer mortality
throughout the world [1]. Epidemiological studies have
shown a significant difference in colon cancer incidence
among different ethnic groups. The incidence of colon
cancer is much higher in the United States and European
countries compared with Asian countries, such as Japan
and China, which is believed to be partially due to dietary
habits [1, 2]. One of the major differences in diet between
these populations is that Americans and Europeans consume
larger amounts of fats than Japanese and Chinese. Animal
fats, especially saturated fats, have been regarded as the
most important nutritional influence on the development of
colon cancer [3].
Lipid peroxidation is a free-radical-initiated chain
oxidation of polyunsaturated fatty acids (PUFAs). PUFAs
are converted into hydroperoxides and aldehydes under
oxidative stress. To date, there has been no overall systemic
investigation concerning the influences of lipid hydro-
peroxides and aldehydes on the growth of colorectal cancer.
The present study demonstrated that among lipid hydro-
peroxides and aldehydes, 4-oxononenal (4-ONE) strongly
inhibited the growth of human colorectal cancer cell line
HT-29. Furthermore, the present study indicated that 4-ONE
induced apoptosis of HT-29 cells through the formation ofS. Sakuma et al.
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activated caspase-3 from pro-caspase-3 by the decreased
expression of Bcl-2.
Materials and Methods
Materials
Linoleic (LA), arachidonic (AA) and eicosapentaenoic
(EPA) acids were obtained from Sigma Chemical Co. (St.
Louis, MO). 4-Hydroxynonenal (4-HNE), 4-hydroxyhexenal
(4-HHE) and 4-ONE were purchased from Cayman
Chemical Co. (Ann Arbor, MI). 13-Hydroperoxyoctadec-
adienoic (13-HPODE) and 15-hydroperoxyeicosapentaenoic
(15-HPEPE) acids were obtained from Cascade Biochem
Ltd. (Berkshire, UK). All other reagents were of analytical
grade.
Cell culture
Human colorectal cancer cell line HT-29 cells (European
Collection of Cell Cultures, Wiltshire, UK) were cultured in
McCoy’s 5A medium (Gibco BRL, Life Technologies,
Carlsbad, CA) with 10% fetal calf serum (Nichirei
Biosciences Inc., Tokyo, Japan) at 37°C in 5% CO2 and 95%
humidity. HT-29 cells were subcultured at appropriate
intervals to maintain subconfluent growth conditions. All
drugs were prepared in Me2SO and added to the medium
at up to 0.25%. Preliminary experiments demonstrated no
significant effects of this Me2SO concentration on the cell
growth and apoptosis of HT-29.
Cell growth assay
Cell growth was quantified using an MTT assay [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
assay]. HT-29 cells were seeded in 6-well plates at 50,000
cells/2 mL/10 cm2 well. One day after seeding, the medium
was changed, and the cells were incubated with the test
compounds for 48 h. The medium was removed and the
cells incubated with 1.1 mL of MTT solution (0.1 mL of
5 mg/mL MTT in 1 mL of medium) for 4 h. MTT is
converted to a blue formazan product by mitochondrial
succinate dehydrogenase. The product was eluted from cells
by the addition of an equal volume of 20% SDS/0.01 N HCl,
and absorbance at 595 nm was determined using a plate
reader (model 550, Bio-Rad, Richmond, CA). Cell viability
was calculated according to the equation: cell viability
(%) = (the absorbance of experiment group/the absorbance
of control groups) × 100.
Apoptosis detection
HT-29 cells were seeded in flexiPERM (Greiner bio-one,
Monroe, NC) put on slides at 25,000 cells/1 mL/5 cm2 well.
One day after seeding, the medium was changed, and the
cells were incubated with the test compounds for 24 h.
Apoptotic cells in the culture were analyzed by an in situ
TUNEL assay using an ApopTag Plus Fluorescein in situ
Apoptosis Detection Kit from Chemicon International Inc.
(Temecula, CA). Apoptosis was also confirmed by DNA
ladder formation analysis. In this analysis, cells were seeded
in dishes at 500,000 cells/10 mL/75 cm2. One day after
seeding, the medium was changed, and the cells were
incubated with the test compounds for 24 h. At the end of the
incubation, the cells were collected by centrifugation and
washed with ice-cold PBS. Genomic DNA was extracted
using a DNA Extractor WB kit from Wako Pure Chemical
Industries, Limited (Tokyo, Japan). After being electro-
phoresed in 2% agarose gels, DNA was visualized by
ethidium bromide staining and visualized using a lumino-
image analyzer (model LAS-3000, Fuji-film, Tokyo, Japan).
Western blot analysis
HT-29 cells were seeded in dishes at 500,000 cells/10 mL/
75 cm2. One day after seeding, the medium was changed,
and the cells were incubated with the test compounds for
12 h. At the end of the incubation, the cells were collected by
centrifugation, washed with ice-cold PBS, and then lysed.
Cell lysates were analyzed using a SDS-7.5% polyacryla-
mide gel. Proteins were transferred to nitrocellulose mem-
branes by electroblotting and the membranes were incubated
overnight in TBS-T (0.14 M NaCl, 20 mM Tris and 0.1%
Tween 20, pH 7.4) containing primary antibodies (anti-pro-
caspase 3 and anti-caspase-3 from Cayman Chemical Co.)
and 3% nonfat dry milk. Proteins were detected using
an ECL detection method (Amersham-Pharmacia Corp.,
Buckingham, UK).
Quantitative real-time RT-PCR analysis
HT-29 cells were seeded in dishes at 500,000 cells/10 mL/
75 cm2. One day after seeding, the medium was changed,
and the cells were incubated with the test compounds for
12 h. At the end of the incubation, the cells were collected by
centrifugation, washed with ice-cold PBS, and total RNA
was extracted using an RNeasy midi kit (Qiagen, German-
town, MD). Total RNA (2.5 μg) was reverse transcribed into
cDNA using a Transcriptor First Strand cDNA synthesis kit
(Roche Diagnostics, Indianapolis, IN), and quantitative real-
time PCR was carried out as described previously [4, 5]
using a LightCycler-FastStart DNA master SYBR Green I
kit (Roche Diagnostics) and LightCycler apparatus (Roche
Diagnostics). The expression levels were normalized by that
of β-actin (Search LC, Heidelberg, Germany). The primers
were as follows: Bcl-2, F: 5'-TGC ACC TGA CGC CCT
TCA C-3', R: 5'-AGA CAG CCA GGA GAA ATC AAA
CAG-3'; Bax, F: 5'-ACC AAG AAG CTG AGC GAG TGT
C-3', R: 5'-ACA AAG ATG GTC ACG GTC TGC C-3'. The
presence of the expected PCR products after quantitative
real-time RT-PCR reactions (293 bp for Bcl-2, 332 bp for
Bax, and 329 bp for β-actin) were confirmed by an agaroseLipid Peroxidation and Colon Cancer
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gel electrophoresis (data not shown).
Caspase-3 assay
Changes in caspase-3 activity were assayed using a
Caspase-3 Colorimetric Assay kit (Alexis Biochemicals,
Lausen, Switzerland). HT-29 cells were seeded in dishes at
500,000 cells/10 mL/75 cm2. One day after seeding, the me-
dium was changed, and the cells were incubated with the test
compounds for 12 h. The medium was removed, and the
cells were lysed. After centrifugation, the supernatant frac-
tions obtained were incubated with DEVD-p-nitroanilide
(200 μM) for 2 h at 37°C, and the absorbance at 400 nm was
measured.
Statistics
Results are means ± SE. Statistical significance was
determined by Student’s t test.
Results and Discussion
Fig. 1 shows the results of cell viability after 48 h treat-
ment with n-6 (LA and AA) and n-3 (EPA) PUFAs, and
hydroperoxy adducts of LA (13-HPODE) and EPA (15-
HPEPE). These fatty acids and hydroperoxides had no sig-
nificant effect on the growth of HT-29 cells at concentrations
of 1 and 10 μM. On the other hand, Fig. 2 illustrates the
efficacies of unsaturated aldehydes generated from 13-
HPODE (4-HNE and 4-ONE) and from 15-HPEPE (4-HHE)
[6] on the growth of HT-29 cells. No significant alteration
was observed with 4-HNE and 4-HHE at concentrations
ranging from 1 to 10 μM, whereas 4-ONE potently reduced
HT-29 cell growth at concentrations of 5 and 10 μM (59
and 85% inhibition).
To clarify the mechanism by which 4-ONE inhibited
HT-29 cell growth, its effects on the DNA fragmentation
(Fig. 3), the expression levels of Bcl-2 and Bax mRNA
(Fig. 4), the activity of caspase-3 and protein expression
levels of pro-caspase-3 and caspase-3 (Fig. 5) were
observed. Using the TUNEL method, DNA fragmentation
was found as the fluorescence of small DNA particles in
nuclei, when 4-ONE (10 μM) was added to HT-29 cells
(Fig. 3a). The fragmentation of DNA in nuclei by incubation
with 4-ONE (10 μM) was also visualized by agarose-gel
electrophoresis of nuclear extracts (Fig. 3b); 4-ONE treat-
Fig. 1. Effects of linoleic (LA), arachidonic (AA) and eicosapentaenoic (EPA) acids, and 13-hydroperoxyoctadecadienoic (13-
HPODE) and 15-hydroperoxyeicosapentaenoic (15-HPEPE) acids on the growth of HT-29 cells. HT-29 cells were incubated
with or without 1 or 10 μM LA, AA, EPA, 13-HPODE and 15-HPEPE for 48 h at 37°C in a humidified atmosphere of 5% CO2.
Cell growth was assayed by an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide]. Each bar indicates the
mean of 3 experiments; vertical lines show SE. PUFA, polyunsaturated fatty acid.S. Sakuma et al.
J. Clin. Biochem. Nutr.
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Fig. 2. Effects of 4-hydroxynonenal (4-HNE),
4-hydroxyhexenal (4-HHE) and 4-ox-
ononenal (4-ONE) on the growth of
HT-29 cells. HT-29 cells were incubated
with or without 1, 5 or 10 μM 4-HNE,
4-HHE and 4-ONE for 48 h at 37°C in a
humidified atmosphere of 5% CO2. Cell
growth was assayed by an MTT. Each
bar indicates the mean of 4–5 experi-
ments; vertical lines show SE. *p<0.01
vs control.
Fig. 3. Detection of 4-ONE-induced DNA degradation in HT-29 cells using fluorescence microscopy (a) and agarose gel electrophore-
sis (b). HT-29 cells were incubated with or without 10 μM 4-ONE and 20 ng/mL of TNF-α for 24 h at 37°C in a humidified at-
mosphere of 5% CO2. Data are representative of at least three independent experiments.Lipid Peroxidation and Colon Cancer
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ment resulted in small-sized DNA debris electrophoresed
from the origin. Thus, 4-ONE showed DNA fragmentation
in HT-29 cells in the same manner as TNF-α (positive
control [7, 8]). As shown in Fig. 4, 4-ONE (10 μM) did
not have any effect on Bax mRNA expression level, whereas
it dramatically reduced the expression level of Bcl-2.
Furthermore, 4-ONE (10 μM) enhanced the activity of
caspase-3 in HT-29 cells (Fig. 5a). This might be partially
due to a tentative increase in activated caspase-3 concomi-
tant with a tentative decrease in pro-caspase-3 (Fig. 5b).
It has been reported that overexpression of Bcl-2 in
transgenic models leads to the protection of many cell types
against apoptosis, suggesting that Bcl-2 exerts an anti-
apoptotic function [9, 10]. Anti-apoptotic activity of Bcl-2
was found to be antagonized by a homologous Bax protein,
which was able to form heterodimers with Bcl-2. Pro-
apoptotic Bax forms the channels for cytochrome c release
that may initiate the activation of caspase-3 identified as the
major caspase that contributes to the hallmark of apoptosis,
while anti-apoptotic Bcl-2 prevents the opening of mito-
chondrial transition pores by binding Bax [11, 12]. Thus,
the present study indicated that 4-ONE induces cell
apoptosis by affecting the ratio of Bax to Bcl-2, activating
cytochrome c release, and inducing proteolytic cleavage of
pro-caspase-3 to activated caspase-3.
Also, is there any specificity to a particular cell, tumor or
histological type in the growth inhibitory and cytotoxic
effects of 4-ONE? When 4-ONE (10 μM) was added to a
human colorectal cancer cell CACO-2, human hepato-
cellular carcinoma cell HepG2, mouse preadipocyte cell
3T3-L1 and rat primary hepatocyte cell, the growth inhibi-
tion was detected in all these cells (67–93% inhibition).
So, it seems likely that 4-ONE can be an inhibitor of cell
proliferation or cell growth, independent of cell types.
Lipid peroxidation is a paradox of aerobic life, affecting
human health and quality of life [13]. Biological systems are
Fig. 4. Effects of 4-ONE on the mRNA expression level of Bcl-2 and Bax in HT-29 cells. HT-29 cells were incubated with or without
10 μM 4-ONE for 12 h at 37°C in a humidified atmosphere of 5% CO2. Each bar indicates the mean of 4–5 experiments;
vertical lines show SE. *p<0.05 vs control.
Fig. 5. Effects of 4-ONE on the activity of caspase-3 (a), and on the protein expression levels of pro-caspase-3 and caspase-3 (b) in
HT-29 cells. HT-29 cells were incubated with or without 10 μM 4-ONE for 12 h at 37°C in a humidified atmosphere of 5%
CO2. Each bar indicates the mean of 3–4 experiments; vertical lines show SE. *p<0.01 vs control.S. Sakuma et al.
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lipid-rich matrices susceptible to autoxidation unless pro-
tected by either endogenous enzymatic or non-enzymatic
mechanisms. On the other hand, various lipid peroxidative
products are generated physiologically and some of them are
known as haemostatic regulators in cells [13]. Lipid per-
oxidation has been suggested to be involved in the control of
cell division [14, 15]. Dreher and Junod [16] also showed
that low levels of oxygen free radicals stimulate cell pro-
liferation, whereas high levels induce cytotoxicity and cell
death in later stages of carcinogenesis. Pillai et al. [ 17]
and Srihari et al. [ 18] have reported that, using 1,2-
dimethylhydrazine (DMH)-induced rat colon carcinogenesis,
levels of lipid peroxidation byproducts, thiobarbituric acid-
reactive substances (TBARS) and conjugated dienes (CD),
in the rat liver are higher, whereas those levels in the colon
and caecum are significantly lowered, as compared with
control rats. Kamaleeswari and Nalini [19] have also shown
that, in addition to TBARS and CD, lipid peroxide levels in
the colon cancer tissue are lower in DMH-treated rats, as
compared with control rats. Furthermore, in vivo studies on
human colon adenocarcinoma have shown decreased
TBARS and 4-HNE contents in the tumor tissue related to
malignancy progression [20,  21]. The chemical reactions
that lead to 4-ONE production have been the subject of
considerable investigation. A likely pathway involves the
breakdown of n-6 derived polyunsaturated fatty acid hydro-
peoxides (e.g., 13-HPODE) to 4-hydroperoxynonenal (4-
HPNE), which can dehydrate to 4-ONE or be reduced to
4-HNE [6]. Both 4-HPNE and 4-ONE have been isolated
as products of lipid peroxidation, and 4-ONE has been
demonstrated to be a powerful electrophile, capable of
reacting with protein and DNA at rates significantly greater
than 4-HNE [22, 23]. The physiological concentration of
4-HNE in rat tissues can reach up to 3 μM [6], and therefore
it might be possible that 4-ONE also appears in the tissues at
micromolar concentration range under normal physiological
states. Cancer cells acquire particular characteristics that
benefit their proliferation [24]. Namely, the present study
might suggest that decreased 4-ONE, which is speculated to
be associated with tumor progression, favors the prolifera-
tion of colon cancer.
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